A cohort study reported that severe myopathy characterized by muscle contractures and atrophy was associated with anti-NXP2 antibody-positive JDM [12], and 43% of anti-NXP2 antibody-positive JDM patients have a relapse [11]. The gene discussed is MORC3; the disease is juvenile dermatomyositis.